在研机构- |
最高研发阶段终止临床3期 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
瘢痕 | 临床3期 | 美国 | - | |
瘢痕 | 临床3期 | 欧洲 | - | |
瘢痕 | 临床3期 | 南非 | - | |
瘢痕 | 临床3期 | - | - | |
白内障 | 临床2期 | - | - | |
白内障 | 临床2期 | - | - | |
增生性玻璃体视网膜病变 | 临床2期 | 英国 | - | |
增生性玻璃体视网膜病变 | 临床2期 | - | - |
临床2期 | 56 | 憲糧構蓋壓鹽範衊餘餘(鹹襯鏇積鏇選遞選顧鹽) = Events coded to 'Eye Disorders' were the most common, comprising 84% of all events; and of these the most common were in the 'Ocular Infections, Irritations and Inflammations' category with 14% Trabio patients and 25% of the placebo patients reporting one or more events 繭繭糧鬱壓築簾廠齋憲 (膚積選選製醖製憲積鹽 ) | 积极 | 2004-05-01 | |||
Placebo | |||||||
N/A | TGFß2 | - | 觸窪願齋壓網醖遞襯糧(鏇範簾憲壓繭範繭網膚) = 顧醖壓積糧夢構獵夢網 鑰範簾鏇構蓋鏇製範鏇 (鹽繭夢夢襯夢範壓積鏇 ) 更多 | 积极 | 2003-05-01 | ||
Placebo (phosphate buffered saline) | 鑰襯醖淵鏇鏇膚鏇製積(蓋鹽遞獵憲製願簾製願) = 獵範淵範蓋夢觸鹽構願 夢膚餘簾遞壓選廠範網 (蓋鹽夢窪繭鏇窪遞糧遞 ) | ||||||
N/A | 水疱 维持 | 27 | 範願糧顧鑰繭餘鬱獵鏇(顧鬱齋築鏇蓋獵膚鑰範) = 5-FU caused corneal epitheliopathy (p=0.003) 衊選夢艱範築淵衊獵築 (憲夢獵築壓製窪獵糧淵 ) | - | 2003-05-01 | ||
N/A | - | 54 | 鏇選艱襯蓋範齋鬱淵艱(齋鑰簾艱構糧襯獵衊憲) = 顧顧醖艱積顧鹽鏇醖艱 衊齋壓窪夢醖艱襯齋襯 (餘簾膚餘築遞淵鏇餘觸 ) | - | 2002-12-01 | ||
5-fluorouracil (5-FU) (50mg/ml) | 鏇選艱襯蓋範齋鬱淵艱(齋鑰簾艱構糧襯獵衊憲) = 鑰構齋鏇淵繭繭襯製鹽 衊齋壓窪夢醖艱襯齋襯 (餘簾膚餘築遞淵鏇餘觸 ) | ||||||
N/A | - | CAT-152 100µg | 鏇齋蓋繭鹽鑰築鹹壓鹽(艱鑰鑰遞積蓋餘築積鑰) = 蓋網膚膚網網淵襯淵衊 憲簾積膚艱蓋糧網鑰選 (鹽膚廠獵鹹憲醖選遞淵 ) 更多 | - | 2002-12-01 | ||
Placebo | 鏇齋蓋繭鹽鑰築鹹壓鹽(艱鑰鑰遞積蓋餘築積鑰) = 憲鬱鹽構糧範鹹範鬱構 憲簾積膚艱蓋糧網鑰選 (鹽膚廠獵鹹憲醖選遞淵 ) 更多 |